Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


12.02.2024

19 Ann Surg Oncol
4 Anticancer Res
2 BMC Gastroenterol
2 Br J Cancer
1 Cancer
3 Dig Dis
4 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
3 Int J Cancer
2 J Clin Oncol
3 J Surg Oncol
4 Oncology
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. TONELLO M, Sommariva A
    ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.
    Ann Surg Oncol. 2024;31:2008-2009.
    PubMed        

  2. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    ASO Visual Abstract: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
    Ann Surg Oncol. 2024;31:2017-2018.
    PubMed        

  3. SARFATY E, Khajoueinejad N, Yu AT, Hiotis S, et al
    Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:1970-1979.
    PubMed         Abstract available

  4. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    ASO Visual Abstract: The Effectiveness of Screening Total Colonoscopy for Preoperative Patients with Gastric Cancer.
    Ann Surg Oncol. 2024;31:1800-1801.
    PubMed        

  5. RYU S, Goto K, Imaizumi Y, Nakabayashi Y, et al
    Laparoscopic Colorectal Surgery with Anatomical Recognition with Artificial Intelligence Assistance for Nerves and Dissection Layers.
    Ann Surg Oncol. 2024;31:1690-1691.
    PubMed         Abstract available

  6. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
    Novel Use of the Falciform Ligament for MHV Reconstruction During Laparoscopic Hepatectomy of Colorectal Liver Metastasis.
    Ann Surg Oncol. 2024;31:1835.
    PubMed         Abstract available

  7. WU CY, Ye K
    The Application Prospect of Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer is Broad.
    Ann Surg Oncol. 2024;31:1702-1703.
    PubMed        

  8. SARFATY E, Cohen NA
    ASO Author Reflections: Achieving Long-Term Survival in Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:2010-2011.
    PubMed        

  9. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    ASO Author Reflections: Biopsychosocial Late Effects are Frequent and Negatively Impact Quality of Life Following Curatively Intended Surgery for Colorectal and Appendiceal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:1696-1697.
    PubMed        

  10. BEDRIKOVETSKI S, Traeger L, Fitzsimmons T, Price TJ, et al
    Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.
    Ann Surg Oncol. 2024;31:1681-1689.
    PubMed         Abstract available

  11. SARFATY E, Khajoueinejad N, Yu AT, Hiotis S, et al
    ASO Visual Abstract: Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:2021.
    PubMed        

  12. MIRZA MB, Smith PM, Wang Y, Naveed A, et al
    Intra-Patient Heterogeneity in Micro-satellite-stable Colorectal Metastases: Does Immunotherapy Have a Role in Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2024;31:1440-1443.
    PubMed        

  13. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    ASO Visual Abstract: Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study.
    Ann Surg Oncol. 2024;31:2014-2015.
    PubMed        

  14. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
    ASO Visual Abstract: Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
    Ann Surg Oncol. 2024;31:2016.
    PubMed        

  15. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study.
    Ann Surg Oncol. 2024;31:1959-1969.
    PubMed         Abstract available

  16. BEDRIKOVETSKI S, Traeger L, Sammour T
    ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer.
    Ann Surg Oncol. 2024;31:1692-1693.
    PubMed        

  17. PIKOULIS E, Papaconstantinou D, Pikouli A, Pararas N, et al
    Is Precision Surgery Applicable to Colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.
    Ann Surg Oncol. 2024;31:1823-1832.
    PubMed         Abstract available

  18. RADOMSKI SN, Dunworth M, West JJ, Greer JB, et al
    Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.
    Ann Surg Oncol. 2024;31:1996-2007.
    PubMed         Abstract available

  19. BEDRIKOVETSKI S, Traeger L, Fitzsimmons T, Price TJ, et al
    ASO Visual Abstract: Association Between RAS/BRAF Mutations and Complete Response After Total Neoadjuvant Therapy of Patients with Rectal Cancer: A Prospective Multicentered Study.
    Ann Surg Oncol. 2024;31:1698-1699.
    PubMed        


    Anticancer Res

  20. KOBAYASHI Y, Uemura M, Paku M, Kitakaze M, et al
    Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer.
    Anticancer Res. 2024;44:695-701.
    PubMed         Abstract available

  21. KOMORI K, Kinoshita T, Sato Y, Ouchi A, et al
    Novel Repair Technique for Oral and Anal Side Stoma Prolapse of a Loop Colostomy With the Stapled Modified Altemeier Method Using Indocyanine Green Fluorescence Imaging.
    Anticancer Res. 2024;44:853-857.
    PubMed         Abstract available

  22. KE TW, Zwane ST, Chiang SF, Chen TW, et al
    Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma.
    Anticancer Res. 2024;44:787-796.
    PubMed         Abstract available

  23. IMAOKA K, Ohira M, Shimomura M, Hattori M, et al
    Effect of Abdominal Aortic Calcification on Recurrence Following Initial Hepatectomy for Colorectal Liver Metastases.
    Anticancer Res. 2024;44:649-658.
    PubMed         Abstract available


    BMC Gastroenterol

  24. BRIGGS NL, Ton M, Malen RC, Reedy AM, et al
    Colorectal cancer pre-diagnostic symptoms are associated with anatomic cancer site.
    BMC Gastroenterol. 2024;24:65.
    PubMed         Abstract available

  25. MIHARA Y, Hirasaki M, Horita Y, Fujino T, et al
    Correction: PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study.
    BMC Gastroenterol. 2024;24:67.
    PubMed        


    Br J Cancer

  26. FLECCHIA C, Auclin E, Alouani E, Mercier M, et al
    Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
    Br J Cancer. 2024;130:442-449.
    PubMed         Abstract available

  27. HSIEH HH, Chen CL, Chan HW, Chi KH, et al
    Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma.
    Br J Cancer. 2024;130:406-416.
    PubMed         Abstract available


    Cancer

  28. HE MM, Wang K, Lo CH, Zhang Y, et al
    Post-diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study.
    Cancer. 2024 Feb 6. doi: 10.1002/cncr.35234.
    PubMed         Abstract available


    Dig Dis

  29. NAKAOKA M, Chiba H, Kobayashi M, Okada N, et al
    Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome.
    Dig Dis. 2024;42:31-40.
    PubMed         Abstract available

  30. XIAO Q, Eckardt M, Mohamed A, Ernst H, et al
    Onset Time and Characteristics of Postprocedural Bleeding after Endoscopic Resection of Colorectal Lesions: A Multicenter Retrospective Study.
    Dig Dis. 2024;42:78-86.
    PubMed         Abstract available

  31. YANG MM, Usiskin K, Ahmad HA, Ather S, et al
    Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.
    Dig Dis. 2023 Sep 27. doi: 10.1159/000533395.
    PubMed         Abstract available


    Dis Colon Rectum

  32. MARKS JH, Reif de Paula T, Saidi H, Ikner TP, et al
    Longitudinal Analysis of Local Recurrence and Survival After Transanal Abdominal Transanal Radical Proctosigmoidectomy for Low Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Dis Colon Rectum. 2024;67:377-386.
    PubMed         Abstract available

  33. KUMAR NAN, Palod A, Ahmed S
    Laparoscopic Intersphincteric Resection for Low Rectal Cancer.
    Dis Colon Rectum. 2024;67:e201.
    PubMed        

  34. HANAOKA M, Takaoka A, Iwata N, Yamauchi S, et al
    Tips for Robotic-Assisted Lateral Lymph Node Dissection With Internal Iliac Artery Resection After Neoadjuvant Chemoradiotherapy.
    Dis Colon Rectum. 2024;67:e199.
    PubMed        

  35. KIM HJ, Choi GS, Cho SH, Kang MK, et al
    Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
    Dis Colon Rectum. 2024;67:359-368.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  36. COHEN S, Hyer W, Attard T
    Endoscopy in pediatric polyposis syndromes: why, when and how.
    Eur J Gastroenterol Hepatol. 2024;36:255-263.
    PubMed         Abstract available


    Int J Cancer

  37. LEE V, Parkinson R, Zahurak M, Cope L, et al
    A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34845.
    PubMed         Abstract available

  38. NUMMELA P, Zafar S, Veikkolainen E, Ukkola I, et al
    GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines.
    Int J Cancer. 2024 Feb 6. doi: 10.1002/ijc.34865.
    PubMed         Abstract available

  39. NORS J, Gotschalck KA, Erichsen R, Andersen CL, et al
    Incidence of late recurrence and second primary cancers 5-10 years after non-metastatic colorectal cancer.
    Int J Cancer. 2024 Feb 7. doi: 10.1002/ijc.34871.
    PubMed         Abstract available


    J Clin Oncol

  40. CHEN L, Wang Y, Cai C, Ding Y, et al
    Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.
    J Clin Oncol. 2024 Feb 5:JCO2301080. doi: 10.1200/JCO.23.01080.
    PubMed         Abstract available

  41. VERHEIJ FS, Omer DM, Williams H, Lin ST, et al
    Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
    J Clin Oncol. 2024;42:500-506.
    PubMed         Abstract available


    J Surg Oncol

  42. XU F, Yang XY, Hu Q
    Prediction of symptomatic anastomotic leak after rectal cancer surgery.
    J Surg Oncol. 2024;129:665-667.
    PubMed        

  43. AKTURK ESEN S, Uncu D
    Is the watch-and-wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer?
    J Surg Oncol. 2024;129:459-460.
    PubMed        

  44. LO WM, Dogeas E, Etherington MS, Ferrone C, et al
    Long-term overall survival in patients undergoing liver resection for metastatic anal squamous cell carcinoma.
    J Surg Oncol. 2024;129:568-573.
    PubMed         Abstract available


    Oncology

  45. MIYAGAWA Y, Kitazawa M, Tokumaru S, Nakamura S, et al
    Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
    Oncology. 2024;102:114-121.
    PubMed         Abstract available

  46. VIVALDI C, Genovesi V, Ugolini C, Bernardini L, et al
    Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
    Oncology. 2024;102:157-167.
    PubMed         Abstract available

  47. JATHO A, Myung SK, Kim J, Han SS, et al
    Consumption of Sugar-Sweetened Soft Drinks and Risk of Gastrointestinal Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
    Oncology. 2024;102:141-156.
    PubMed         Abstract available

  48. MATSUNAKA T, Goi T, Kurebayashi H, Morikawa M, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer.
    Oncology. 2024;102:99-106.
    PubMed         Abstract available


    PLoS One

  49. SRIVASTAVA S, Kak I, Major P, Bonert M, et al
    What is your count? An observational study of lymph node counting in 2,028 colorectal cancer resections.
    PLoS One. 2024;19:e0295209.
    PubMed         Abstract available

  50. BOURMOUM M, Radulovich N, Sharma A, Tkach JM, et al
    beta-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53.
    PLoS One. 2024;19:e0295030.
    PubMed         Abstract available

  51. AHADINEZHAD B, Maleki A, Akhondi A, Kazemi M, et al
    Are behavioral economics interventions effective in increasing colorectal cancer screening uptake: A systematic review of evidence and meta-analysis?
    PLoS One. 2024;19:e0290424.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.